StockComparison Logo
vs

NCEL vs JSPR

Comparison between NLS Pharmaceutics Ltd (NCEL, Company) and Jasper Therapeutics Inc (JSPR, Company).

Both NCEL and JSPR are from the Healthcare sector.

5-Year PerformanceJSPR has outperformed NCEL, delivering a return of -67.8% compared to -68.2%

NCEL vs JSPR - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
Winner
NCEL
$17M
JSPR
$17M
Max Drawdown
NCEL
99.92%
Winner
JSPR
99.79%
Sharpe Ratio
Winner
NCEL
-0.93
JSPR
-1.10
5Y Beta
Winner
NCEL
0.63
JSPR
1.47
Industry
NCEL
Biotechnology
JSPR
Biotechnology
P/E Ratio
Winner
NCEL
-2.03
JSPR
-0.22
Debt to Equity
NCEL
4.90%
Winner
JSPR
0.00%
Free Cash Flow Yield
NCEL
-16.43%
JSPR
N/A
P/B Ratio
Winner
NCEL
2.59
JSPR
5.87

NCEL vs JSPR - Historical Returns

Returns include dividend reinvestment.

1M
NCEL
-8.16%
Winner
JSPR
+47.46%
3M
Winner
NCEL
-23.78%
JSPR
-33.68%
6M
Winner
NCEL
+29.28%
JSPR
-58.05%
1Y
NCEL
-83.28%
Winner
JSPR
-79.03%
5Y(CAGR)
NCEL
-68.24%
Winner
JSPR
-67.83%
Max(CAGR)
Winner
NCEL
-65.44%
JSPR
-67.83%

NCEL vs JSPR - Annual Returns (2021 - 2026)

Returns include dividend reinvestment.

YearNCELJSPR
2026+60.83%-66.26%
2025-91.28%-91.32%
2024-91.03%+214.13%
2023-57.86%-71.20%
2022+8.40%-93.97%
2021-61.59%-48.08%

NCEL vs JSPR Drawdown Comparison

The maximum drawdown for NCEL was -99.92%, occurring on Mar 30, 2026. This drawdown has not yet recovered.

The maximum drawdown for JSPR was -99.79%, occurring on Jun 26, 2026. This drawdown has not yet recovered.

The current NCEL drawdown is -99.86%. The current JSPR drawdown is -99.62%.

RankNCELJSPR
#1-99.92%
Mar 12, 2021 - Mar 30, 2026
-99.79%
Oct 15, 2021 - Jun 26, 2026
#2-35.41%
Feb 11, 2021 - Mar 12, 2021
-52.31%
Sep 24, 2021 - Oct 15, 2021
#3-9.34%
Jan 29, 2021 - Feb 3, 2021
N/A
#4-7.69%
Feb 4, 2021 - Feb 11, 2021
N/A

Correlation

Correlation between NCEL and JSPR is 0.72 which considered as a strong positive correlation - the stocks tend to move together.

0.72
-101

Select Stocks to Compare